Feedback
Settings

Settings

Goto Application

1. WO2006047948 - THE USE OF HUMAN URINARY KALLIDINOGENASE FOR THE MANUFACTURE OF A MEDICINE FOR THE TREATMENT OF SEPSIS

PermaLink
Publication Number WO/2006/047948
Publication Date 11.05.2006
International Application No. PCT/CN2005/001829
International Filing Date 02.11.2005
IPC
A61K 38/48 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
43Enzymes; Proenzymes; Derivatives thereof
46Hydrolases (3)
48acting on peptide bonds (3.4)
A61K 9/19 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders
19lyophilised
A61K 9/08 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
08Solutions
A61P 31/00 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
CPC
A61K 38/4853
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
43Enzymes; Proenzymes; Derivatives thereof
46Hydrolases (3)
48acting on peptide bonds (3.4)
482Serine endopeptidases (3.4.21)
4853Kallikrein (3.4.21.34 or 3.4.21.35)
A61K 9/0019
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
0012Galenical forms characterised by the site of application
0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
A61K 9/19
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
14Particulate form, e.g. powders, ; Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
19lyophilised ; , i.e. freeze-dried, solutions or dispersions
A61P 31/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
31Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Applicants
  • TECHPOOL BIO-PHARMA CO., LTD. [CN]/[CN] (AllExceptUS)
  • FU, Heliang [CN]/[CN] (UsOnly)
  • MIAO, Piqu [CN]/[CN] (UsOnly)
  • WANG, Xiaoyan [CN]/[CN] (UsOnly)
  • XIE, Yongli [CN]/[CN] (UsOnly)
Inventors
  • FU, Heliang
  • MIAO, Piqu
  • WANG, Xiaoyan
  • XIE, Yongli
Agents
  • BEIJING SUNHOPE INTELLECTUAL PROPERTY LTD.
Priority Data
200410088441.803.11.2004CN
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) THE USE OF HUMAN URINARY KALLIDINOGENASE FOR THE MANUFACTURE OF A MEDICINE FOR THE TREATMENT OF SEPSIS
(FR) APPLICATION DE LA KALLIDINOGÉNASE DE L’URINE HUMAINE DANS LA FABRICATION D’UN MÉDICAMENT POUR LE TRAITEMENT DE SEPSIES
Abstract
(EN) The present invention relates to a novel pharmaceutical use of human urinary kallidinogenase in the manufacture of a medicine for the prevention and/or treatment of sepsis£¬and the pharmaceutical composition comprising human urinary kallidinogenase as active ingredient. The human urinary kallidinogenase and the pharmaceutical compositions containing the same are effective for the prevention and/or treatment of sepsis. The human urinary kallidinogenase and the pharmaceutical composition containing the same can be used in various formulation forms, preferably in the form of dry powder or liquid for injection.
(FR) La présente invention a pour objet une nouvelle application pharmaceutique de la kallidinogénase de l’urine humaine dans la fabrication d’un médicament pour le traitement prophylactique et/ou thérapeutique de sepsies, ainsi qu'une préparation pharmaceutique comprenant ladite kallidinogénase au titre de principe actif. Ladite kallidinogénase, ainsi que les préparations pharmaceutiques la contenant, peuvent être employées dans le traitement prophylactique et/ou thérapeutique de sepsies. Ladite kallidinogénase et lesdites préparations peuvent être employées sous de nombreuses formes galéniques, préférentiellement sous forme de poudre sèche ou de solution pour injection.
Related patent documents
CN1695735
Latest bibliographic data on file with the International Bureau
# -